KRMAYURVED

KRM Ayurveda Share Price

 

 

Start SIP in KRMAYURVED

Start SIP

Performance

  • Low
  • ₹169
  • High
  • ₹178
  • 52 Week Low
  • ₹165
  • 52 Week High
  • ₹184
  • Open Price₹178
  • Previous Close₹178
  • Volume172,000
  • 50 DMA-
  • 100 DMA-
  • 200 DMA-

Investment Returns

  • Over 1 Month + 25.15%
  • Over 3 Month + 25.15%
  • Over 6 Month + 25.15%
  • Over 1 Year + 25.15%

Smart Investing Starts Here Start SIP with KRM Ayurveda for Steady Growth!

Invest Now

KRM Ayurveda Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 29.7
  • PEG Ratio
  • -
  • Market Cap Cr
  • 359
  • P/B Ratio
  • 8.6
  • Average True Range
  • -
  • EPS
  • 0
  • Dividend Yield
  • 0
  • MACD Signal
  • -
  • RSI
  • -
  • MFI
  • -

KRM Ayurveda Financials

KRM Ayurveda Technicals

EMA & SMA

Current Price
₹168.95
-8.85 (-4.98%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 0
  • 20 Day
  • -
  • 50 Day
  • -
  • 100 Day
  • -
  • 200 Day
  • -

Resistance and Support

171.92 Pivot Speed
  • R3 183.78
  • R2 180.82
  • R1 174.88
  • S1 165.98
  • S2 163.02
  • S3 157.08

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

N/A

Group Rank

KRM Ayurveda F&O

KRM Ayurveda Shareholding Pattern

No data available.

About KRM Ayurveda

  • NSE Symbol
  • KRMAYURVED
  • BSE Symbol
  • Managing Director
  • Mr. Puneet Dhawan
  • ISIN
  • INE1MTV01019

Similar Stocks to KRM Ayurveda

KRM Ayurveda FAQs

KRM Ayurveda share price is ₹168 As on 02 February, 2026 | 02:19

The Market Cap of KRM Ayurveda is ₹359.2 Cr As on 02 February, 2026 | 02:19

The P/E ratio of KRM Ayurveda is 29.7 As on 02 February, 2026 | 02:19

The PB ratio of KRM Ayurveda is 8.6 As on 02 February, 2026 | 02:19

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23